Vericel
Manufacturing · Massachusetts, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
64 Sidney St, Cambridge, Massachusetts, ...Phone Number
(617) 588-5555Website
www.vcel.comRevenue
$292.1 MillionStock Symbol
VCELIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
3
1
1
1
1
About Vericel
Vericel Corporation is a commercial-stage biopharmaceutical company incorporated in 1989 and headquartered in Cambridge, Massachusetts, focused on the development, manufacture, and commercialization of advanced cell therapies and specialty biologic products. The company serves the sports medicine and severe burn care markets in North America, offering a portfolio of autologous cell therapy products and a licensed specialty biologic for burn treatment. Its products are sold through orthopedic surgeons, sports medicine specialists, and specialized burn care centers across the United States. Vericel combines innovations in cell biology with medical technology to deliver differentiated therapies that repair injuries and address serious medical conditions. The company was formerly known as Aastrom Biosciences, Inc. and adopted its current name in November 2014. Vericel trades on the NASDAQ under the ticker symbol VCEL.Explore more
Vericel Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vericel your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Vericel is spiking on competitors!
Earning: See what the market has to say on Vericel recently announced quarterly report
Funding: Get notified immidiatlly once Vericel has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Vericel launches new products
Click to see if Vericel had a recent Job posting/layoffs
Check if Vericel has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Vericel
Vericel, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Vericel
Compare insights from companies similar to Vericel, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vericel is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vericel is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vericel.
Vericel financials insights
Gather financial insights about Vericel, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2010
Stock Offering
$12.4M
Stock Offering
$20.5M
2012
Share Placement
$38M
2013
Stock Offering
$9M
2014
Private Equity
$15M
Stock Offering
$40.3M
2016
Stock Offering
$20M
2017
Debt
$25M
2018
Stock Offering
$74.8M
Vericel Tech Stack
A closer look at the technologies used by Vericel
Most Recent Scoops
Hiring Plans
Vericel has more open roles in Operations than it has had at any time in the past 12 months. Areas of expertise include: Inventory Problem Resolution, Requirements Specifications, Materials Management, Loading Operations, and Cross-Functional Collaboration.
Hiring Plans
Person-Based
Earnings, Sales, Finance
Person-Based
Earnings, Finance
Person-Based
Stake & Stock Ownership, Finance, Financial Transactions
Person-Based
Accounting, Finance, Financial Transactions
Vericel News & Media
The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
Issued on behalf of Conexeu Sciences Inc.Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026
BURLINGTON, Mass., June 09, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16th, 2026.Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More
Vericel develops cell therapies for cartilage repair and burn care, serving hospitals and clinics across the United States.Analysts Have Made A Financial Statement On Vericel Corporation's (NASDAQ:VCEL) First-Quarter Report
A week ago, Vericel Corporation ( NASDAQ:VCEL ) came out with a strong set of first-quarter numbers that could...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vericel
Sign Up For FreeTo access detailed company insights
Vericel Corporation is a commercial-stage biopharmaceutical company incorporated in 1989 and headquartered in Cambridge, Massachusetts, focused on the development, manufacture, and commercialization of advanced cell therapies and specialty biologic products. The company serves the sports medicine and severe burn care markets in North America, offer... Read More
